Early oxytocin treatment in infants with Prader–Willi syndrome is safe and is associated with better endocrine, metabolic and behavioral outcomes
Gwénaëlle Diene, Grégoire Benvegnu, Mélanie Glattard, Catherine Arnaud et al.
Citations
6 citations
Journal
Orphanet Journal of Rare Diseases
Topics
Genetic Syndromes and Imprinting
Field-Weighted Citation Impact (FWCI)
10.90
article
Early oxytocin treatment in infants with Prader–Willi syndrome is safe and is associated with better endocrine, metabolic and behavioral outcomes
Gwénaëlle Diene, Grégoire Benvegnu, Mélanie Glattard, Catherine Arnaud, Marion Valette, Jean‐Pierre Salles, M. Tauber, Pierre Payoux, Sandy Faye, Sophie Çabal, Julie Cortadellas, Kader Boulanouar, Catherine Molinas
article en
6 citations
Abstract
No abstract available for this paper.
Publication Tag
Orphanet Journal of Rare DiseasesVol. 20(1)
Institutions
Centre National de la Recherche Scientifique (FR), Université Toulouse III - Paul Sabatier (FR), Inserm (FR), Université Fédérale de Toulouse Midi-Pyrénées (FR), Centre Hospitalier Universitaire de Toulouse (FR), Hôpital Purpan (FR), Clinique Pasteur (FR), Hôpital des Enfants (FR)